XHR New Technology, Skin, Subcutaneous Tissue, Fascia and Breast, Replacement
Non-billable header ICD10PCS Release FY2026-APR
Short description: New Tech, Skin & Breast, Subcu Tiss & Fascia, Replace
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| FY2026 | 2025-10-01 | 2026-03-31 | New Technology, Skin, Subcutaneous Tissue, Fascia and Breast, Replacement | no |
| FY2026-APR | 2026-04-01 | current | New Technology, Skin, Subcutaneous Tissue, Fascia and Breast, Replacement | no |
Related codes in XHR
- XHR0XGA Replacement of Head and Neck Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR1XGA Replacement of Chest Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR2XGA Replacement of Abdomen Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR3XGA Replacement of Back Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR4XGA Replacement of Right Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR5XGA Replacement of Left Upper Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR6XGA Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHR7XGA Replacement of Left Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- XHRPXF7 Replacement of Skin with Bioengineered Allogeneic Construct, External Approach, New Technology Group 7